Anika Therapeutics | Pasivo Circulante

Precio De Mercado
14.18
Cambio Diario
-0.14 -0.98%
Mensual
32.90%
Anual
-15.90%
Q1 Expectativa
13.92




Pasivo Circulante Cambio Fecha
Abbott USD 16.5B 1.91B 2025-12
Agenus USD 287.13M 52.57M 2025-09
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Anika Therapeutics USD 19.09M 3.01M 2025-09
Arrowhead Research USD 347.42M 151.94M 2025-12
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Heron Therapeutics USD 89.71M 168.89M 2025-09
Insmed USD 468.87M 51.66M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
Intrexon USD 23.02M 38K 2024-06
J&J USD 54.13B 3.26B 2025-12
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
MacroGenics USD 44.47M 5.47M 2025-09
Merit Medical Systems USD 239.76M 9.29M 2025-12
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 3.76B 2025-12
Smith & Nephew USD 1.54B 236M 2025-12
Stryker USD 7.79B 380M 2025-12
Surmodics USD 20.54M 347K 2024-09
Veracyte USD 59.94M 12.22M 2025-12
Xencor USD 95.91M 9.42M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12


Anika Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.